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Abstract
Background: Colorectal cancer (CRC) screening rates are low in many areas and cost-effective interventions to
promote CRC screening are needed. Recently in a randomized controlled trial, a mailed educational reminder
increased CRC screening rates by 16.2% among U.S. Veterans. The aim of our study was to assess the costs and
cost-effectiveness of a mailed educational reminder on fecal occult blood test (FOBT) adherence.
Methods: In a blinded, randomized, controlled trial, 769 patients were randomly assigned to the usual care group
(FOBT alone, n = 382) or the intervention group (FOBT plus a mailed reminder, n = 387). Ten days after picking up
the FOBT cards, a 1-page reminder with information related to CRC screening was mailed to the intervention
group. Primary outcome was number of returned FOBT cards after 6 months. The costs and incremental cost-
effectiveness ratio (ICER) of the intervention were assessed and calculated respectively. Sensitivity analyses were
based on varying costs of labor and supplies.
Results: At 6 months after card distribution, 64.6% patients in the intervention group returned FOBT cards
compared with 48.4% in the control group (P < 0.001). The total cost of the intervention was $962 or $2.49 per
patient, and the ICER was $15 per additional person screened for CRC. Sensitivity analysis based on a 10% cost
variation was $13.50 to $16.50 per additional patient screened for CRC.
Conclusions: A simple mailed educational reminder increases FOBT card return rate at a cost many health care
systems can afford. Compared to other patient-directed interventions (telephone, letters from physicians, mailed
reminders) for CRC screening, our intervention was more effective and cost-effective.
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Background
Colorectal cancer (CRC) is one of the leading causes of
cancer-related deaths in the United States and a com-
mon cause of morbidity and mortality worldwide [1]. In
2008, about 148,000 new cases of CRC will be diag-
nosed, and about 50,000 people will die from this dis-
ease [2]. Several randomized controlled trials have
shown evidence for the effectiveness of fecal occult
blood testing (FOBT) in reducing CRC mortality by
using samples from three successive stools [3,4]. In one
randomized trial, annual FOBT followed by colonoscopy
in those with a positive test reduced colorectal cancer
mortality by 33% [5]. The impact of FOBT screening on
CRC incidence and mortality is likely due to the early
detection and removal of precancerous adenomatous
polyps and earlier stage cancers.
National efforts have been made to increase awareness
of CRC screening over the past several years. Recently,
the United States Preventive Services Task Force
(USPSTF) and National Comprehensive Cancer Network
(NCCN) recommend all individuals aged 50 to 75 years,
who are at average risk for CRC to use one of the fol-
lowing methods for CRC screening: an annual high sen-
sitivity FOBT, a flexible sigmoidoscopy every 5 years, or
a colonoscopy every 10 years [6,7]. Despite these recom-
mendations and guidelines, CRC screening rates remain
low. As of 2006, almost 50% of adults age 50 years or
older were not up-to-date with CRC screening [2].
Numerous studies have shown that patient compliance
in CRC screening programs and FOBT card return rates
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any medium, provided the original work is properly cited.are suboptimal [8-11]. As a result, interest in cost-effec-
tive patient-directed interventions to promote CRC
screening remains keen.
Recently, we reported that a mailed educational
reminder increased FOBT card return rate for CRC
screening by 16.2% (P < 0.001) at a large Veteran Affairs
(VA) medical center [12]. However, it is not known if
our intervention was cost-effective, particularly in the
context of other similar cancer screening promotion
programs. Given the highly constrained resources for
health promotion, it is essential for decision makers to
require information on the costs and cost-effectiveness
of the interventions. Although there have been several
studies on the economics of cervical cancer and mam-
mography screening promotion [13,14], few studies have
evaluated the cost-effectiveness of patient or provider-
directed interventions for CRC screening in average risk
patients, especially in the VA population [15-20]. The
primary aim of this study is to assess the costs and cost-
effectiveness of our mailed educational reminder on
adherence with FOBT-type screening among the U.S.
Veteran population.
Methods
Data for this study were collected in 2007 and analyses
were conducted in 2008-2009. Detailed descriptions of
the design, methods, primary, and secondary outcomes
of the randomized controlled trial on using a mailed
educational reminder to increase FOBT card return
rates have been published [12]. Here we provide a brief
summary of the clinical trial and analytic methods below
Clinical Trial
To test the effect of a mailed educational reminder on
increasing FOBT card return rate for CRC screening, we
conducted a double-blind, randomized controlled trial
in a U.S. Veteran patient population. Patients meeting
inclusion criteria (age ≥ 50, not up to date with CRC
screening) were randomly assigned to receive either
usual care or usual care with a mailed educational
reminder (intervention), which was mailed 10 days after
the patients received their FOBT cards from the labora-
tory. All patients were given 6 months to return the
FOBT cards.
Study Setting and Population
We evaluated patients from three VA primary care
clinics in San Diego and Vista, California between June
1 and September 9, 2007. The study included asympto-
matic men and women age 50 years or older who
agreed with screening and received FOBT card kits with
a postage paid return envelope. Under usual care, pri-
mary care physicians (PCP) entered a computerized
order for FOBT for CRC screening, and then patients
were instructed by their PCP to pick up FOBT cards
from the laboratory and return them for analysis.
Patients were excluded from this study if they were less
than 50 years of age, were currently on an inpatient
unit, were up-to-date with CRC screening, or refused to
undergo any routine CRC screening. We did not
exclude any patients over the age of 75 as recommended
by the USPSTF in 2008, because our study was per-
formed prior to the 2008 guidelines [6].
Intervention
The mailed educational reminder consisted of an 8.5 ×
11 paper folded in thirds, personalized, sealed, and sent
to the subjects’ home address 10 days after the patients
were given their FOBT cards by the clinical laboratory
(Additional file 1, Appendix 1). The mailed letter was
one-sided, written at an eighth-grade reading level [21],
and contained a reminder to return their FOBT cards
on the top portion of the letter. The middle portion of
the letter had several statements regarding the risk of
developing CRC, who is affected by the disease, and the
benefits of getting screened. On the bottom third of the
letter was a quote from a United States Veteran colon
cancer survivor, who emphasized the importance of col-
orectal cancer screening. The Institutional Review Board
(IRB) at our institution granted exemption of an
informed consent because of the minimal risk associated
with the mailed reminder and a guarantee of at least
usual care for all patients.
Cost Analysis
An analysis of costs was conducted from the payer’s
perspective to help better represent the costs that a
healthcare system may incur when offering interventions
of this type. The payer’s perspective will allow health-
care organizations to gauge approximately what it would
cost for them to conduct a similar program in the
future; assuming adjustmentsa r em a d ef o ri n f l a t i o n .
Intervention costs were based on the actual personnel
time and materials used in the mailed reminder and are
detailed in the next section. All research related activ-
ities were excluded from the cost analysis.
Costs of the Intervention
To calculate the costs of our intervention, we identified
all inputs used for the intervention. The cost of our
intervention included the cost of creating the letter con-
tent by a physician, editing and approving the content
by management (Gastroenterology (GI) section chief),
the time to generate and personalize the mailed remin-
ders by an administrative assistant, overhead costs, and
finally the cost of the mailed reminder itself including
paper, envelopes, pen, printer ink, and postage (Table
1). Personnel cost estimates were derived from actual
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an administrative assistant, $150,000 per year for a phy-
sician, and $200,000 per year for a VA staff gastroenter-
ologist. The labor costs were calculated by multiplying
the time spent of performing the task (creating the letter
content, editing and approving the content, generating,
personalizing, and mailing the reminder) by the employ-
ee’s wage per hour. We determined the costs of all
materials used for the mailed reminder by multiplying
the costs of each material by the number of patients
receiving the mailed reminder. Overhead costs were
estimated at 69% of the personnel costs required to deli-
ver the intervention, which accounts for facilities costs,
indirect support personnel, and other typical indirect
costs associated with running an outpatient healthcare
program [22]. This figure of 69% is based on data show-
ing that only half of all healthcare reimbursement costs
are related to direct provision of care and that roughly
69% of non-care costs are indirect costs [23,24]. This
method has been used in the cost analyses of other
similar trials [25]. Other costs, such as those associated
with research and development (R&D) activity were
excluded. First-copy costs, defined as costs incurred in
establishing an intervention, are considered quasi-fixed
costs independent of the number of units produced
once production is started [26]. In general, first-copy
costs are excluded when they involve situations where
much of the intervention is already in existence and
only modification is needed to adapt it for implementa-
tion [14]. This is assuming that the final product can be
made available to other health care organizations
through public access [14]. Furthermore, it is expected
that managed care organizations or community clinics
would not develop their own mailed reminder but
would rely on public access or licensing arrangements.
Cost-effectiveness Analysis
The incremental cost-effectiveness ratio (ICER) was
derived based on the difference in the costs assigned to
the intervention and control groups divided by the dif-
ference in FOBT card return rates between the interven-
tion and control groups. The result is a measure of
efficiency, reported as dollars per additional patient
screened. The lower the result (ICER), the more efficient
is the intervention. Sensitivity analysis estimates were
based on a 10% and 25% variation around the point esti-
mates for the various cost inputs (i.e. labor costs, mate-
rial costs, the effectiveness of the intervention) [27]. In
addition, the ICER was similarly calculated for various
subgroups including gender, race, age, current illicit
drug use, current alcohol use, current tobacco use, psy-
chiatric disorders, and history of prior FOBT completion
Table 1 Cost of the Mailed Educational Reminder (Intervention)
Item Costs Provider Patients Time
(h)
Cost/
h
Total $
Cost
Sensitivity
Analysis
(± 10%)
Sensitivity
Analysis
(± 25%)
Startup Costs
Creating the letter content Physician* 0.25 $72.12 $18 $64.80-79.20 $13.50-22.50
Management Costs (editing & approving the reminder) Chief GI
Physician**
0.25 $96.12 $24 $21.60-26.40 $18.00-30.00
Total Startup Costs $42 $37.80-46.20 $31.50-52.50
Maintenance Costs
Generating, personalizing & mailing the reminder
Overhead (69% of personnel costs
Assistant*** 387 0.05 $19.23 $372 $334.80-409.20 $279.00-465.00
personnel costs 387 $286 $257.40-314.60 $214.50-357.50
Envelopes ($0.10) 387 $39 $35.10-42.90 $29.25-48.75
Reminder ($0.10) 387 $39 $35.10-42.90 $29.25-48.75
Postage ($0.42) 387 $163 $146.70-179.30 $122.25-203.75
Printer ink ($0.05) 387 $19 $17.10-20.90 $14.25-23.75
Pens $2 “tabcaption”.80-
2.20
“tabcaption”.50-
2.50
Total Maintenance Costs $920 $828.00-
1012.00
$690.00-
1150.00
Total Cost $962 $865.80-
1058.20
$721.50-
1202.50
Total Cost/Patient $2.49 $2.24-2.74 “tabcaption”.87-
3.11
* Based on physician salary for a primary care physician at the VA: $150,000
** Based on VA gastroenterology physician salary: $200,000
*** Based on administrative assistant salary at the VA: $40,000
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and compiled a list of other ICER for patient-directed
CRC screening promotion interventions.
Results
Study Participants
Among 846 patients who received FOBT cards for CRC
screening during our 3-month enrollment period, 769
were determined eligible and were randomized to
receive either a mailed educational reminder (n = 387)
or usual care (n = 382). The baseline demographic and
clinical characteristics were well matched in both the
control and intervention groups [12]. The mean age of
our study participants was 63.1 years (SD = 9.6). The
majority of our study participants were male (96.3%),
Caucasian (72.8%), and not married (56.6%); the largest
minority group in the cohort was African-Americans
(11.7%). Many members of the cohort were currently
drinking alcohol (45.0%) and smoking tobacco (27.6%),
b u to n l yaf e ww e r en o t e dt ob ec u r r e n t l yo rr e c e n t l y
using illicit drugs (6.5%). Major psychiatric disorders
present in our cohort were anxiety disorders (11.3%)
and mood disorders (28.9%).
Effectiveness of the Intervention
The proportion of patients who returned the FOBT
cards was significantly higher in the mailed reminder
group than those who did not receive a reminder. At 6
months after card distribution, the FOBT card return
rate in the intervention and control arms were 64.6%
(250/387) and 48.4% (185/382), respectively (P < 0.001)
(Figure 1). The percent incremental effect was 16.2 per-
centage points and the absolute difference in FOBT card
returned was 65. The timing of the return of FOBT kits
was previously published, and the data indicated that
39-49% of patients returned kits by 30 days in the usual
care and intervention control arms, respectively; and
this increased to 47-62% by 90 days and to 48-65% by
180 days [13].
Intervention Costs
The total cost of the intervention was $962, which is
$2.49 per patient (Table 1). Our startup costs, which
consisted of labor costs of creating the letter content by
a physician and editing and approving the content by
management (GI physician) came out to be $42. Our
maintenance costs were $920, and consisted of labor
costs from the administrative assistant who generated
and personalized the mailed reminders, overhead costs
(69% of personnel costs), and the cost of the mailed
reminder itself including paper, envelopes, pen, printer
ink, and postage. The time spent by a physician on
researching and creating the content of the letter was
about fifteen minutes. The time spent on editing and
approving the content of the reminder was about fifteen
minutes. Lastly, the time spent on generating, persona-
lizing, and mailing the reminder was estimated to be
around 3 minutes. Sensitivity estimates based on a 10%
variation around the cost inputs revealed a total cost of
the intervention ranging from $865.80 - $1058.20. Note
that patient-related calls to administrative or nursing
staff were not measured, but may have contributed to
maintenance costs and the 10-25% variation estimates.
Cost-effectiveness
The incremental cost-effectiveness ratio (ICER) for the
mailed educational reminder (intervention) was $15 per
additional person screened (Table 2). The ICER was
obtained from the difference in costs per patient
between the intervention and control groups ($2.49)
divided by the difference in FOBT card return rates
between the intervention and control groups (16.2%).
Since costs included in this intervention may vary in dif-
ferent locations, we performed a sensitivity analysis for
costs based on a 10% to 25% variation around the cost
inputs (Table 1 and Table 3). Sensitivity estimates based
on a 10% variation revealed that the estimated cost per
additional patient screened for CRC ranged from $13.50
to $16.50. Sensitivity estimates based on a 25% variation
revealed that the estimated cost per additional patient
screened for CRC ranged from $11.25 to $18.75. For
comparison, ICERs for other published patient directed
interventions for CRC screening are listed in Table 4. In
order to determine how differences in screening compli-
ance in different patient subgroups affected the cost-
effectiveness, we performed a subgroup analysis. As
depicted in Table 3, the intervention had a similar
ICER, ranging from $5.65 to $27.07 per additional per-
son screened across various subgroups of patients.
Totalno.ofpatients
n=769
UsualCare=382patients
Reminder=387patients
197didnotreturnFOBT(51.6%)
250returnedtheFOBT(64.6%)
137didnotreturnFOBT(35.8%)
185returnedtheFOBT(48.4%)
Totalcost=$0
Totalcost=$943
Figure 1 Study Diagram of Intervention to Promote Colorectal
Cancer Screening. Flow diagram and results of randomized trial of
intervention vs. usual care for colon cancer screening. 769 patients
were enrolled and 382 were randomized to the control group,
which received FOBT alone, and 387 patients were randomized to
the intervention group, which was a mailed reminder 14 days after
receiving their FOBT. The FOBT card return rate after 6 months was
64.6% in the intervention group compared to 48.4% in the usual
care group (p < 0.001).
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Asians appear to have the lowest ICER in our subgroup
analyses for reasons that remain unclear. Further studies
are needed to help understand and confirm this finding.
Discussion
Our economic analysis demonstrates that a low-intensity
patient-directed intervention is inexpensive, effective,
and cost-effective. A simple mailed educational remin-
der, mailed 10 days after patients picked up their FOBT
cards from the laboratory, significantly increased FOBT
card return rate by 16.2% compared to the control
group (64.4% vs. 48.4%, P < 0.001) [12]. The total cost
of our intervention was $962, which came out to be
$2.49 per individual in our study population. More
importantly, the incremental cost of our intervention
was $15 per additional individual screened for CRC,
which is markedly lower compared to other patient-
directed interventions for CRC screening (Table 4). In
the past 15 years, several studies have demonstrated the
effectiveness of tailored interventions in increasing CRC
screening compliance, but few have examined these
interventions from a cost perspective [8,10,15,28,29]. To
date, our study is the first study that estimates the costs
and cost-effectiveness of a patient-directed intervention
(mailed educational reminder) on CRC screening among
U.S. Veterans at average risk of developing CRC.
Prior studies on cost-effectiveness of patient-directed
interventions for CRC screening have shown mixed
results (Table 4), with costs ranging from $43 to $5842
per additional individual screened for CRC [17,18,20,27].
In one study, Lairson and colleagues randomized their
patients who received FOBT and flexible sigmoidoscopy
(FS) referrals to either two rounds of mailed reminders,
Table 2 Incremental Cost-effectiveness (Intervention cost per additional individual screened)
Intervention Cost Incremental
cost
Effect %
Screened
Incremental
effect, %
Incremental
cost-effectiveness
Usual Care (control) 0 - 48.4 - -
Mailed Reminder $2.49 $2.49 64.6 16.2 $15
Table 3 ICER of the Mailed Reminder Intervention by Subgroup
Subgroups Usual care
% FOBT
card return
rate
Mailed
reminder
% FOBT card
return rate
% Effect Marginal
Cost
ICER Sensitivity
Analysis
(±10%)
Sensitivity
Analysis
(±25%)
All patients, n = 769 48.4% 64.6% 16.2% $2.49 $15.00 $13.50-16.50 $11.25-18.75
Race
White, n = 560 52.2% 61.6% 9.4% $2.49 $26.49 $23.84-29.14 $19.87-33.11
Black, n = 90 35.0% 77.6% 42.6% $2.49 $5.85 $5.26-6.44 $4.39-7.31
Hispanic, n = 58 40.0% 51.9% 11.9% $2.49 $20.92 $18.83-23.01 $15.69-26.15
Other (Asians, etc), n = 61 41.1% 85.2% 44.1% $2.49 $5.65 $5.08-6.22 $4.24-7.06
Males, n = 741 47.4% 64.4% 17.0% $2.49 $14.65 $13.18-16.12 $10.99-18.31
Females, n = 28 60.0% 69.2% 9.2% $2.49 $27.07 $24.36-29.78 $20.30-33.84
Age
50 - 59 years, n = 336 40.5% 60.1% 19.6% $2.49 $12.70 $11.43-13.97 $9.52-15.88
60 - 69 years, n = 250 50.0% 66.4% 16.4% $2.49 $15.18 $13.60-16.70 $11.38-18.98
>70 years, n = 183 59.8% 70.9% 11.1% $2.49 $22.43 $20.19-24.67 $16.82-28.04
Current illicit drug use, n = 50 20.8% 39.1% 18.3% $2.49 $13.61 $12.25-14.97 $10.21-17.01
Current alcohol use, n = 346 50.3% 62.1% 16.7% $2.49 $14.91 $13.42-16.40 $11.18-18.64
Current tobacco use, n = 212 35.4% 60.3% 11.8% $2.49 $21.10 $18.99-23.21 $15.82-26.38
Psychiatric disease
Anxiety disorder, n = 87 57.1% 66.7% 9.6% $2.49 $25.94 $23.35-28.53 $19.45-32.43
Mood disorder, n = 222 40.4% 58.9% 18.5% $2.49 $13.46 $12.11-14.81 $10.09-16.83
Psychotic disorder, n = 22 54.5% 36.4% -18.1% $2.49 - - -
No. of prior FOBT completed
None, n = 384 39.6% 49.5% 9.9% $2.49 $25.15 $22.63-27.67 $18.86-31.44
1, n = 187 49.4% 69.8% 23.4% $2.49 $10.64 $9.58-11.70 $7.98-13.30
2, n = 90 64.3% 87.2% 22.9% $2.49 $10.87 $9.78-11.96 $8.15-13.59
3, n = 108 70.2% 86.2% 16.0% $2.49 $15.56 $14.00-17.12 $11.67-19.45
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of reminder telephone calls along with the tailored
mailed reminder [18]. Their results showed that increas-
ingly intensive patient-directed interventions resulted in
higher ICERs, with the most unfavorable ICER of $5842
coming from the addition of a reminder telephone call
to a tailored mailed reminder [18]. The ICER of two
rounds of mailed reminders was $319 per additional
patient screened [18]. There are several reasons for the
higher ICER compared to our study including the num-
ber of mailed reminders (two reminders), which
increased labor, supply, and postage costs, the lower
incremental effect (13.2% compared to our 16.2%) from
their intervention, and the costs of mailing the FOBT
cards to every study participant [18].
In a study at a university-based ambulatory care cen-
ter, Lewis et al. implemented a multi-modal interven-
tion, which included a letter from their PCP, a colon
cancer screening decision aid, and instructions for
obtaining each screening test without an office visit so
that patients could access screening tests directly [17].
Although effective in increasing CRC screening rates by
11%, the ICER for that intervention was $94 per extra
person screened for CRC [17]. Despite the significant
increase in CRC screening rates, there were several lim-
itations to the study including a modest sample size (n
= 237), non-randomized study design, and the difficulty
to determine the relative degree to which compliance
was influenced by the reminder itself, the colon cancer
screening decision aid, or the removal of system barriers
by eliminating office visits. It is also possible that these
additional materials have benefits beyond increased
screening rates.
Recently, Sequist et al. demonstrated that mailing a
tailored letter along with an FOBT kit improved CRC
screening rates by 6% [20]. In this study, 21,860 patients
from 11 health centers in Eastern Massachusetts were
randomized to receive a mailing that included a tailored
letter, an educational brochure, a dedicated telephone
number to schedule a flexible sigmoidoscopy or colono-
scopy, and an FOBT kit. Participants that were still
overdue for CRC screening 6 months after initial enroll-
ment of the study received a mailed reminder. The cost
of the intervention was $5.48 per patient and the ICER
Table 4 ICERs for other Patient-Directed Interventions to Improve Colorectal Cancer Screening
Study Patients Target Population Target CRC
screening
test
Cost of Intervention Intervention Baseline
Screening
Rate
Change in
Effectiveness
ICER
Lee et al.
2009
775 Veterans aged ≥ 50
years who were
average risk for CRC
FOBT Mailed Reminder $2.49 48.4% 16.2% $15
Lewis et
al. 2008
237 Patients in a
University-based
practice age ≥50
years who were
average risk for CRC
FOBT, FS,
colonoscopy
Mailed package that included a
letter from their PCP, a CRC
screening decision aid, and
instructions for obtaining each
screening test without an
office visit
$11 4% 11% $94
Lairson et
al. 2007
1546 Patients in a
University-based
practice ages 50-74
years who were
average risk for CRC
FOBT, FS,
colonoscopy
barium
enema
Patients randomized into 4
groups: control, standard
group (SI) consisting of mailed
informational brochure,
invitation letter, FOBT cards,
and reminder letter; tailored
intervention (TI) consisting of
standard intervention plus
motivational messages based
on patient-specific survey data;
tailored interventions (TIP)
consisting of tailored
intervention plus reminder
phone call
$42 for SI
$150 for TI
$200 for TIP
33% 13% for SI TI
and TIP did not
yield much
significant
change in
effective ness
$319
for SI
$5842
for TIP
Shankaran
et al. 2006
781 Patients in a
University-based
practice ages ≥50
years who received
referrals for screening
colonoscopy
Colonoscopy Mailed informational Brochure/
Reminder
$5 59% 12% $43
Sequist et
al. 2010
21,860 Patients aged 50-80
years across 11 health
centers who were
average risk for CRC
FOBT, FS,
colonoscopy
Patient mailing with FOBT kit,
telephone line to schedule
colonoscopy, and mailed
reminder 6 months later
$5.48 38% 6% $94
FOBT: Fecal occult blood test, CRC: Colorectal cancer, FS: Flexible sigmoidoscopy
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study showed promising results, the intervention could
only be applied in a large integrated medical group with
a well-established electronic health record. In addition,
the improvement in screening rates was about one half
of what we observed in our study, and as a result, the
ICER was much higher than what we report. Similar to
our study, although not related to FOBT adherence,
Shankaran et al. were able to show that a 1-page, 2-
sided mailed reminder significantly increased colono-
scopy appointment adherence by 12% and had an ICER
of $43 per additional person screened for CRC [27].
However, the cost inputs for Shankaran’s study were not
reported clearly, particularly the initial data costs, poten-
tially making the intervention difficult to replicate [27].
Personnel cost, particularly using our administrative
assistant to generate and mail the reminder, were the
most significant cost to our intervention. With rising
costs of health care, one should consider if available,
information technology systems that could generate
mailed reminders from electronic medical records. This
change would significantly decrease the ICER by redu-
cing the number of minutes spent by the administrative
assistant. Given the ease of electronic data acquisition
within the VA healthcare system, we view this to be the
next logical step for intervention implementation.
In recent years, several health maintenance organiza-
tions (HMO), clinics, and primary care physicians have
started using fecal immunochemical tests (FIT) to
improve CRC screening rates. However, studies have
shown that compliance rates with FIT are either slightly
better or similar compared to the guaiac-based tests
[30-32]. Knowing that FIT kits are much more expen-
sive compared to the guaiac-based tests, healthcare
organizations will likely face higher costs associated with
patients not returning the FIT kits compared to the
guaiac-based tests. Although there have not been any
studies evaluating the effectiveness of a mailed reminder
on FIT kit return rates, it is likely that our intervention
could similarly improve FIT kit return rates, thus lower-
ing the costs associated with non-compliance.
There are several limitations to our study. First, our
study was a cost-effectiveness analysis with an inter-
mediate outcome (cost per additional person screened
for CRC). We did not use the standard metric for cost-
effectiveness, which is the cost per year of life saved.
The goal of our study was to increase the utilization of
FOBT, a CRC screening method that has already been
shown to be cost-effective. We understand that cost-
effectiveness ratios do not provide a definitive answer,
b u ti tc a na s s i s tt h ed e c i s ion maker in choosing the
most appropriate intervention given the cost, effective-
ness, and resources available to implement the program.
Secondly, our sample was comprised of U.S. Veteran
patients from San Diego, California, which limits the
generalizability of our findings. More studies are needed
at other VA medical centers, community based medical
centers, and non-VA settings to help establish the inter-
vention’s generalizibility. Third, our study was based on
an analysis from the payer perspective, and costs
incurred by individual patients were not included in the
analysis. Fortunately, FOBT costs to the patient are neg-
ligible in that the patient can perform the test quickly in
his or her home with minimal discomfort or complica-
tions. Lastly, we did not exclude any patients over the
age of 75 as recommended by the USPSTF in 2008 [6],
because our study was performed prior to these
recommendations.
Conclusion
In conclusion, a simple mailed educational reminder
increased FOBT card return rate at a cost many health
care systems can afford. The costs and ICER associated
with this patient-directed intervention was markedly
lower than most analogous CRC screening interventions
and therefore could be recommended for implementa-
tion at this time in practices with similar organizational
and patient characteristics. Cost analyses on promoting
CRC screening interventions should be emphasized in
increasing CRC screening rates in the U.S.
Additional material
Additional file 1: Appendix Mailed Educational Reminder. The mailed
educational reminder used in the intervention.
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